Cargando…

Feline panleukopenia. ABCD guidelines on prevention and management

OVERVIEW: Feline panleukopenia virus (FPV) infects all felids as well as raccoons, mink and foxes. This pathogen may survive in the environment for several months and is highly resistant to some disinfectants. INFECTION: Transmission occurs via the faecal–oral route. Indirect contact is the most com...

Descripción completa

Detalles Bibliográficos
Autores principales: Truyen, Uwe, Addie, Diane, Belák, Sándor, Boucraut-Baralon, Corine, Egberink, Herman, Frymus, Tadeusz, Gruffydd-Jones, Tim, Hartmann, Katrin, Hosie, Margaret J., Lloret, Albert, Lutz, Hans, Marsilio, Fulvio, Pennisi, Maria Grazia, Radford, Alan D., Thiry, Etienne, Horzinek, Marian C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ESFM and AAFP. Published by Elsevier Ltd. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129762/
https://www.ncbi.nlm.nih.gov/pubmed/19481033
http://dx.doi.org/10.1016/j.jfms.2009.05.002
_version_ 1783516858649935872
author Truyen, Uwe
Addie, Diane
Belák, Sándor
Boucraut-Baralon, Corine
Egberink, Herman
Frymus, Tadeusz
Gruffydd-Jones, Tim
Hartmann, Katrin
Hosie, Margaret J.
Lloret, Albert
Lutz, Hans
Marsilio, Fulvio
Pennisi, Maria Grazia
Radford, Alan D.
Thiry, Etienne
Horzinek, Marian C.
author_facet Truyen, Uwe
Addie, Diane
Belák, Sándor
Boucraut-Baralon, Corine
Egberink, Herman
Frymus, Tadeusz
Gruffydd-Jones, Tim
Hartmann, Katrin
Hosie, Margaret J.
Lloret, Albert
Lutz, Hans
Marsilio, Fulvio
Pennisi, Maria Grazia
Radford, Alan D.
Thiry, Etienne
Horzinek, Marian C.
author_sort Truyen, Uwe
collection PubMed
description OVERVIEW: Feline panleukopenia virus (FPV) infects all felids as well as raccoons, mink and foxes. This pathogen may survive in the environment for several months and is highly resistant to some disinfectants. INFECTION: Transmission occurs via the faecal–oral route. Indirect contact is the most common route of infection, and FPV may be carried by fomites (shoes, clothing), which means indoor cats are also at risk. Intrauterine virus transmission and infection of neonates can occur. DISEASE SIGNS: Cats of all ages may be affected by FPV, but kittens are most susceptible. Mortality rates are high – over 90% in kittens. Signs of disease include diarrhoea, lymphopenia and neutropenia, followed by thrombocytopenia and anaemia, immunosuppression (transient in adult cats), cerebellar ataxia (in kittens only) and abortion. DIAGNOSIS: Feline panleukopenia virus antigen is detected in faeces using commercially available test kits. Specialised laboratories carry out PCR testing on whole blood or faeces. Serological tests are not recommended, as they do not distinguish between infection and vaccination. DISEASE MANAGEMENT: Supportive therapy and good nursing significantly decrease mortality rates. In cases of enteritis, parenteral administration of a broad-spectrum antibiotic is recommended. Disinfectants containing sodium hypochlorite (bleach), peracetic acid, formaldehyde or sodium hydroxide are effective. VACCINATION RECOMMENDATIONS: All cats – including indoor cats – should be vaccinated. Two injections, at 8–9 weeks of age and 3–4 weeks later, are recommended, and a first booster 1 year later. A third vaccination at 16–20 weeks of age is recommended for kittens from environments with a high infection pressure (cat shelters) or from queens with high vaccine-induced antibody levels (breeding catteries). Subsequent booster vaccinations should be administered at intervals of 3 years or more. Modified-live virus vaccines should not be used in pregnant queens or in kittens less than 4 weeks of age.
format Online
Article
Text
id pubmed-7129762
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher ESFM and AAFP. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71297622020-04-08 Feline panleukopenia. ABCD guidelines on prevention and management Truyen, Uwe Addie, Diane Belák, Sándor Boucraut-Baralon, Corine Egberink, Herman Frymus, Tadeusz Gruffydd-Jones, Tim Hartmann, Katrin Hosie, Margaret J. Lloret, Albert Lutz, Hans Marsilio, Fulvio Pennisi, Maria Grazia Radford, Alan D. Thiry, Etienne Horzinek, Marian C. J Feline Med Surg Article OVERVIEW: Feline panleukopenia virus (FPV) infects all felids as well as raccoons, mink and foxes. This pathogen may survive in the environment for several months and is highly resistant to some disinfectants. INFECTION: Transmission occurs via the faecal–oral route. Indirect contact is the most common route of infection, and FPV may be carried by fomites (shoes, clothing), which means indoor cats are also at risk. Intrauterine virus transmission and infection of neonates can occur. DISEASE SIGNS: Cats of all ages may be affected by FPV, but kittens are most susceptible. Mortality rates are high – over 90% in kittens. Signs of disease include diarrhoea, lymphopenia and neutropenia, followed by thrombocytopenia and anaemia, immunosuppression (transient in adult cats), cerebellar ataxia (in kittens only) and abortion. DIAGNOSIS: Feline panleukopenia virus antigen is detected in faeces using commercially available test kits. Specialised laboratories carry out PCR testing on whole blood or faeces. Serological tests are not recommended, as they do not distinguish between infection and vaccination. DISEASE MANAGEMENT: Supportive therapy and good nursing significantly decrease mortality rates. In cases of enteritis, parenteral administration of a broad-spectrum antibiotic is recommended. Disinfectants containing sodium hypochlorite (bleach), peracetic acid, formaldehyde or sodium hydroxide are effective. VACCINATION RECOMMENDATIONS: All cats – including indoor cats – should be vaccinated. Two injections, at 8–9 weeks of age and 3–4 weeks later, are recommended, and a first booster 1 year later. A third vaccination at 16–20 weeks of age is recommended for kittens from environments with a high infection pressure (cat shelters) or from queens with high vaccine-induced antibody levels (breeding catteries). Subsequent booster vaccinations should be administered at intervals of 3 years or more. Modified-live virus vaccines should not be used in pregnant queens or in kittens less than 4 weeks of age. ESFM and AAFP. Published by Elsevier Ltd. 2009-07 2009-05-27 /pmc/articles/PMC7129762/ /pubmed/19481033 http://dx.doi.org/10.1016/j.jfms.2009.05.002 Text en Copyright © 2009 ESFM and AAFP. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Truyen, Uwe
Addie, Diane
Belák, Sándor
Boucraut-Baralon, Corine
Egberink, Herman
Frymus, Tadeusz
Gruffydd-Jones, Tim
Hartmann, Katrin
Hosie, Margaret J.
Lloret, Albert
Lutz, Hans
Marsilio, Fulvio
Pennisi, Maria Grazia
Radford, Alan D.
Thiry, Etienne
Horzinek, Marian C.
Feline panleukopenia. ABCD guidelines on prevention and management
title Feline panleukopenia. ABCD guidelines on prevention and management
title_full Feline panleukopenia. ABCD guidelines on prevention and management
title_fullStr Feline panleukopenia. ABCD guidelines on prevention and management
title_full_unstemmed Feline panleukopenia. ABCD guidelines on prevention and management
title_short Feline panleukopenia. ABCD guidelines on prevention and management
title_sort feline panleukopenia. abcd guidelines on prevention and management
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129762/
https://www.ncbi.nlm.nih.gov/pubmed/19481033
http://dx.doi.org/10.1016/j.jfms.2009.05.002
work_keys_str_mv AT truyenuwe felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT addiediane felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT belaksandor felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT boucrautbaraloncorine felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT egberinkherman felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT frymustadeusz felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT gruffyddjonestim felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT hartmannkatrin felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT hosiemargaretj felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT lloretalbert felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT lutzhans felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT marsiliofulvio felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT pennisimariagrazia felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT radfordaland felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT thiryetienne felinepanleukopeniaabcdguidelinesonpreventionandmanagement
AT horzinekmarianc felinepanleukopeniaabcdguidelinesonpreventionandmanagement